​​In January-March, Pfizer earned $ 3.5 billion in vaccine sal | Insider Amigo

​​In January-March, Pfizer earned $ 3.5 billion in vaccine sales, while Moderna earned $ 1.9 billion.

The covid 19 vaccine netted Pfizer $ 3.5 billion in the first three months of this year, nearly a quarter of its total revenue, the company said ahead of its earnings report. The pharmaceutical giant said it expects total vaccine revenues to be around $ 26 billion by 2021, based on contracts signed in mid-April that will ship 1.6 billion doses of the vaccine this year.
@insider_amigo
Pfizer expects to be able to produce at least 2.5 billion doses in 2021 and another 3 billion doses in 2022, CEO Albert Burla said in prepared comments ahead of the teleconference:
“Based on what we have seen, we believe that the strong demand for our COVID-19 vaccine - similar to the demand for influenza vaccines - is a likely outcome.”
The American biotech company Moderna has managed to become profitable for the first time. According to the financial report for the first quarter of 2021, its net profit reached $ 1.2 billion. The company was able to achieve its first quarterly profit in ten years of its history through sales of the vaccine against COVID-19. In the reporting three months, Moderna sold 102 million doses of its coronavirus vaccine, mainly in the United States, which brought the company $ 1.7 billion.In comparison, Moderna's total revenue in the first quarter reached $ 1.9 billion.
https://t.me/insider_amigo
Click to subscribe... Channel is a bomb